PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>42</strong>/<strong>2000</strong><br />
19 Oct/oct <strong>2000</strong> <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 15237<br />
(51) 7 C07C 405/00, A61K 31/5575, A61P 9/00<br />
(11) WO 00/61550 (13) A1<br />
(21) <strong>PCT</strong>/JP00/02286<br />
(22) 7 Apr/avr <strong>2000</strong> (07.04.<strong>2000</strong>)<br />
(25) ja (26) ja<br />
(30) 11/103323 9 Apr/avr 1999<br />
(09.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) PROSTAGLANDIN E1 DERIVATIVES<br />
DERIVES DE PROSTAGLANDINE E1<br />
(71) TAISHO PHARMACEUTICAL CO.,<br />
LTD. [JP/JP]; 24–1, Takata 3–chome, Toshima–ku,<br />
Tokyo 170–8633 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(71, 72) SATO, Fumie [JP/JP]; 2–1–901, Kugenumahigashi,<br />
251–0026 (JP).<br />
Fujisawa–shi, Kanagawa<br />
(72, 75) TANAMI, Tohru [JP/JP]; Taisho<br />
Pharmaceutical Co., Ltd., 24–1, Takata<br />
3–chome, Toshima–ku, Tokyo 170–8633<br />
(JP). TANAKA, Hideo [JP/JP]; Taisho<br />
Pharmaceutical Co., Ltd., 24–1, Takata<br />
3–chome, Toshima–ku, Tokyo 170–8633<br />
(JP). ONO, Naoya [JP/JP]; Taisho Pharmaceutical<br />
Co., Ltd., 24–1, Takata 3–chome,<br />
Toshima–ku, Tokyo 170–8633 (JP). YAGI,<br />
Makoto [JP/JP]; Taisho Pharmaceutical Co.,<br />
Ltd., 24–1, Takata 3–chome, Toshima–ku,<br />
Tokyo 170–8633 (JP). HIRANO, Hitomi<br />
[JP/JP]; Taisho Pharmaceutical Co., Ltd.,<br />
24–1, Takata 3–chome, Toshima–ku, Tokyo<br />
170–8633 (JP).<br />
(74) KITAGAWA, Tomizo; Taisho Pharmaceutical<br />
Co., Ltd. Patent Division, 24–1, Takata<br />
3–chome, Toshima–ku, Tokyo 170–8633<br />
(JP).<br />
(81) AU CA CN JP KR US; EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE).<br />
(51) 7 C07D<br />
(11) WO 00/61551 (13) A2<br />
(21) <strong>PCT</strong>/EP00/02746<br />
(22) 29 Mar/mar <strong>2000</strong> (29.03.<strong>2000</strong>)<br />
(25) de (26) de<br />
(30) 199 16 719.2 13 Apr/avr 1999<br />
(13.04.1999)<br />
(30) 199 62 998.6 24 Dec/déc 1999<br />
(24.12.1999)<br />
JP<br />
DE<br />
DE<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) INTEGRIN RECEPTOR LIGANDS<br />
LIGANDS<br />
D’INTEGRINE<br />
DE RECEPTEURS<br />
(71) BASF AKTIENGESELLSCHAFT<br />
[DE/DE]; D–67056 Ludwigshafen (DE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) ZECHEL, Johann–Christian<br />
[DE/DE]; Schreiberweg 7, D–69226<br />
Nußloch (DE). KLING, Andreas [DE/DE];<br />
Riegeler Weg 14, D–68239 Mannheim<br />
(DE). GENESTE, Hervé [FR/DE]; Rehbachstrasse<br />
<strong>42</strong>, D–67141 Neuhofen (DE).<br />
LANGE, Udo [DE/DE]; Königsstuhlstrasse<br />
15, D–68163 Mannheim (DE). LAUTER-<br />
BACH, Arnulf [DE/DE]; Innsbrucker Weg<br />
7, D–67067 Ludwigshafen (DE). GRAEF,<br />
Claudia, Isabella [DE/DE]; Tullastrasse 10,<br />
D–68161 Mannheim (DE). SUBKOWSKI,<br />
Thomas [DE/DE]; Wichernstrasse 13,<br />
D–68526 Ladenburg (DE). SADOWSKI,<br />
Jens [DE/DE]; Mainstrasse 2, D–67117<br />
Limburgerhof (DE). HORNBERGER,<br />
Wilfried [DE/DE]; Goldener Winkel 14,<br />
D–67434 Neustadt (DE).<br />
(74) BASF AKTIENGESELLSCHAFT;<br />
D–67056 Ludwigshafen (DE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 C07D 207/09, 207/20, 295/14, 217/04,<br />
211/26, A61K 31/40, 31/4453, 31/495,<br />
31/5375, 31/445, A61P 37/06, 43/00<br />
(11) WO 00/61552 (13) A1<br />
(21) <strong>PCT</strong>/JP00/02267<br />
(22) 7 Apr/avr <strong>2000</strong> (07.04.<strong>2000</strong>)<br />
(25) ja (26) ja<br />
(30) 11/100482 7 Apr/avr 1999<br />
(07.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) N–SUBSTITUTED–N’–SUBSTITUTED<br />
UREA DERIVATIVE AND USE THE-<br />
REOF AS TNF– PRODUCTION<br />
INHIBITOR<br />
DERIVE D’UREE N–SUBSTITUE–N’–<br />
SUBSTITUE, ET SON UTILISATION<br />
COMME INHIBITEUR DE LA PRO-<br />
DUCTION DE TNF–<br />
(71) SANTEN PHARMACEUTICAL CO.,<br />
LTD. [JP/JP]; 9–19, Shimoshinjo 3–chome,<br />
Higashiyodogawa–ku, Osaka–shi, Osaka<br />
533–6851 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) MITA, Shiro [JP/JP]; Santen Pharmaceutical<br />
Co., Ltd., 9–19, Shimoshinjo<br />
3–chome, Higashiyodogawa–ku, Osaka–shi,<br />
Osaka 533–6851 (JP). HORIUCHI, Masato<br />
[JP/JP]; Santen Pharmaceutical Co., Ltd.,<br />
9–19, Shimoshinjo 3–chome, Higashiyodogawa–ku,<br />
Osaka–shi, Osaka 533–6851 (JP).<br />
BAN, Masakazu [JP/JP]; Santen Pharmaceutical<br />
Co., Ltd., 9–19, Shimoshinjo<br />
3–chome, Higashiyodogawa–ku, Osaka–shi,<br />
Osaka 533–6851 (JP). SUHARA, Hiroshi<br />
[JP/JP]; Santen Pharmaceutical Co., Ltd.,<br />
9–19, Shimoshinjo 3–chome, Higashiyodogawa–ku,<br />
Osaka–shi, Osaka 533–6851 (JP).<br />
JP<br />
(74) NAKAMURA, Minoru et al. / etc.; Room<br />
646, Shin–Tokyo Bldg, 3–1, Marunouchi<br />
3–chome, Chiyoda–ku, Tokyo 100–8355<br />
(JP).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS KE KG KP KR KZ LC LK LR LS<br />
LT LU LV MA MD MG MK MN MW MX<br />
NO NZ PL PT RO RU SD SE SG SI SK SL<br />
TJ TM TR TT TZ UA UG US UZ VN YU<br />
ZA ZW; AP (GH GM KE LS MW SD SL<br />
SZ TZ UG ZW); EA (AM AZ BY KG KZ<br />
MD RU TJ TM); EP (AT BE CH CY DE<br />
DK ES FI FR GB GR IE IT LU MC NL PT<br />
SE); OA (BF BJ CF CG CI CM GA GN GW<br />
ML MR NE SN TD TG).<br />
(51) 7 C07D 209/08, 209/30, A61K 31/40<br />
(11) WO 00/61553 (13) A1<br />
(21) <strong>PCT</strong>/FR00/00921<br />
(22) 11 Apr/avr <strong>2000</strong> (11.04.<strong>2000</strong>)<br />
(25) fr (26) fr<br />
(30) 99/04576 13 Apr/avr 1999<br />
(13.04.1999)<br />
FR<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) 2–AMINOETHYL–INDOLE DERIVA-<br />
TIVES, THEIR PREPARATION AND<br />
THERAPEUTIC USE<br />
DERIVES DE 2–AMINOETHYL–<br />
INDOLE, LEUR PREPARATION ET<br />
LEUR APPLICATION EN THERAPEU-<br />
TIQUE<br />
(71) SANOFI–SYNTHELABO [FR/FR]; 174,<br />
avenue de France, F–75013 Paris (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BOVY, Philippe, R. [BE/FR]; 13, rue<br />
du 4 Septembre, F–78750 Mareil Marly<br />
(FR). MOUGENOT, Patrick [FR/FR]; 2,<br />
avenue Ossart, F–92500 Rueil Malmaison<br />
(FR). PHILIPPO, Christophe [FR/FR]; 18,<br />
place des Maitres Vignerons, F–92500 Rueil<br />
Malmaison (FR).<br />
(74) THOURET–LEMAITRE, Elisabeth;<br />
Sanofi–Synthelabo, 174, avenue de France,<br />
F–75013 Paris (FR).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 C07D 209/08, A61K 31/40, C07D 209/30,<br />
A61P 43/00<br />
(11) WO 00/61554 (13) A1<br />
(21) <strong>PCT</strong>/FR00/00922<br />
(22) 11 Apr/avr <strong>2000</strong> (11.04.<strong>2000</strong>)